0	0	1998-09-21	CD	O	O	B-Num
0	1	16	CD	O	O	B-Num
0	2	:	:	O	O	I-Num
0	3	37	CD	O	B-NP	I-Num
0	4	PERSONAL	NNP	O	I-NP	O
0	5	HEALTH	NN	O	I-NP	O
0	6	:	:	O	O	O
0	7	THE	DT	O	B-NP	O
0	8	DANGERS	NNP	O	I-NP	O
0	9	OF	IN	O	B-PP	O
0	10	DIETARY	NNP	O	O	O
0	11	SUPPLEMENTS	NNP	O	O	O
0	12	-LBR-	-LBR-	O	O	O
0	13	JT	NNP	O	O	B-Org
0	14	-RBR-	-RBR-	O	O	O

1	0	Growing	VBG	O	B-NP	O
1	1	numbers	NNS	O	I-NP	O
1	2	of	IN	O	B-PP	O
1	3	Americans	NNPS	O	B-NP	B-LangRace
1	4	are	VBP	O	B-VP	O
1	5	stepping	VBG	O	I-VP	O
1	6	daily	JJ	O	O	O
1	7	into	IN	O	B-PP	O
1	8	a	DT	O	B-NP	O
1	9	potential	JJ	O	I-NP	O
1	10	minefield	NN	O	I-NP	O
1	11	of	IN	O	B-PP	O
1	12	substances	NNS	O	B-NP	O
1	13	loosely	RB	O	B-VP	O
1	14	referred	VBD	O	I-VP	O
1	15	to	TO	O	B-PP	O
1	16	as	IN	O	B-PP	O
1	17	dietary	JJ	O	B-NP	O
1	18	supplements	NNS	O	I-NP	O
1	19	COMMA	COMMA	O	O	O
1	20	many	JJ	O	B-NP	O
1	21	of	IN	O	B-PP	O
1	22	which	WDT	O	B-NP	O
1	23	have	VBP	O	B-VP	O
1	24	little	JJ	O	B-NP	O
1	25	or	CC	O	I-NP	O
1	26	nothing	NN	O	I-NP	O
1	27	to	TO	O	B-VP	O
1	28	do	VB	O	I-VP	O
1	29	with	IN	O	B-PP	O
1	30	the	DT	O	B-NP	O
1	31	components	NNS	O	I-NP	O
1	32	of	IN	O	B-PP	O
1	33	foods	NNS	O	B-NP	O
1	34	people	NNS	O	I-NP	O
1	35	normally	RB	O	O	O
1	36	consume	VBP	O	B-VP	O
1	37	.	.	O	O	O

2	0	And	CC	O	O	O
2	1	increasingly	RB	O	O	O
2	2	these	DT	O	B-NP	O
2	3	pill	NN	O	I-NP	O
2	4	poppers	NNS	O	I-NP	O
2	5	are	VBP	O	B-VP	O
2	6	getting	VBG	O	I-VP	O
2	7	into	IN	O	B-PP	O
2	8	trouble	NN	O	B-NP	O
2	9	COMMA	COMMA	O	O	O
2	10	suffering	VBG	O	B-VP	O
2	11	toxic	JJ	O	B-NP	B-Medical
2	12	reactions	NNS	O	I-NP	O
2	13	to	TO	O	B-PP	O
2	14	deliberate	JJ	O	B-NP	O
2	15	or	CC	O	I-NP	O
2	16	accidental	JJ	O	I-NP	O
2	17	components	NNS	O	I-NP	O
2	18	of	IN	O	B-PP	O
2	19	these	DT	O	B-NP	O
2	20	products	NNS	O	I-NP	O
2	21	or	CC	O	O	O
2	22	sacrificing	VBG	O	B-VP	O
2	23	the	DT	O	B-NP	O
2	24	chance	NN	O	I-NP	O
2	25	to	TO	O	B-VP	O
2	26	be	VB	O	I-VP	O
2	27	helped	VBN	O	I-VP	O
2	28	by	IN	O	B-PP	O
2	29	conventional	JJ	O	B-NP	O
2	30	medicine	NN	O	I-NP	B-Medical
2	31	.	.	O	O	O

3	0	Last	JJ	O	B-NP	O
3	1	week	NN	O	I-NP	O
3	2	in	IN	O	B-PP	O
3	3	six	CD	O	B-NP	B-Num
3	4	reports	NNS	O	I-NP	O
3	5	published	VBN	O	B-VP	O
3	6	in	IN	O	B-PP	O
3	7	The	NNP	O	B-NP	B-Loc
3	8	New	NNP	O	I-NP	B-Jour
3	9	England	NNP	O	I-NP	B-Peop
3	10	Journal	NNP	O	I-NP	I-Peop
3	11	of	IN	O	B-PP	I-Jour
3	12	Medicine	NNP	O	B-NP	I-Jour
3	13	COMMA	COMMA	O	O	O
3	14	physicians	NNS	O	B-NP	B-ProfTitle
3	15	described	VBD	O	B-VP	O
3	16	such	JJ	O	B-NP	O
3	17	reactions	NNS	O	I-NP	O
3	18	as	IN	O	O	O
3	19	lead	VBP	O	O	O
3	20	poisoning	NN	O	O	B-Medical
3	21	COMMA	COMMA	O	O	O
3	22	impotence	NN	O	O	B-Medical
3	23	COMMA	COMMA	O	O	O
3	24	blood	NN	O	B-NP	B-Medical
3	25	clots	NN	O	I-NP	I-Medical
3	26	COMMA	COMMA	O	O	O
3	27	abnormal	JJ	O	B-NP	O
3	28	heart	NN	O	I-NP	B-Medical
3	29	rhythms	NN	O	I-NP	O
3	30	COMMA	COMMA	O	O	O
3	31	nausea	NN	O	B-NP	B-Medical
3	32	COMMA	COMMA	O	I-NP	O
3	33	vomiting	NN	O	I-NP	B-Medical
3	34	COMMA	COMMA	O	O	O
3	35	diarrhea	NN	O	B-NP	O
3	36	and	CC	O	I-NP	O
3	37	disorientation	NN	O	I-NP	B-Medical
3	38	from	IN	O	B-PP	O
3	39	exposure	NN	O	B-NP	O
3	40	to	TO	O	B-PP	O
3	41	powerful	JJ	O	B-NP	O
3	42	drugs	NNS	O	I-NP	O
3	43	or	CC	O	O	O
3	44	toxic	JJ	O	B-NP	B-Medical
3	45	contaminants	NNS	O	I-NP	O
3	46	in	IN	O	B-PP	O
3	47	products	NNS	O	B-NP	O
3	48	deemed	VBD	O	B-VP	O
3	49	to	TO	O	I-VP	O
3	50	be	VB	O	I-VP	O
3	51	``	``	O	O	O
3	52	all	RB	O	O	O
3	53	natural	JJ	O	O	O
3	54	''	''	O	O	O
3	55	alternatives	NNS	O	O	O
3	56	to	TO	O	B-PP	O
3	57	established	VBN	O	B-NP	O
3	58	therapies	NNS	O	I-NP	O
3	59	.	.	O	O	O

4	0	The	DT	O	B-NP	O
4	1	reports	NNS	O	I-NP	O
4	2	are	VBP	O	B-VP	O
4	3	a	DT	O	B-NP	O
4	4	reminder	NN	O	I-NP	O
4	5	that	IN	O	O	O
4	6	consumers	NNS	O	B-NP	O
4	7	who	WP	O	B-NP	O
4	8	wander	VBP	O	B-VP	O
4	9	recklessly	RB	O	O	O
4	10	into	IN	O	B-PP	O
4	11	the	DT	O	B-NP	O
4	12	world	NN	O	I-NP	O
4	13	of	IN	O	B-PP	O
4	14	herbs	NNS	O	B-NP	O
4	15	and	CC	O	O	O
4	16	other	JJ	O	B-NP	O
4	17	dietary	JJ	O	I-NP	O
4	18	supplements	NNS	O	I-NP	O
4	19	must	MD	O	B-VP	O
4	20	proceed	VB	O	I-VP	O
4	21	at	IN	O	B-PP	O
4	22	their	PP$	O	B-NP	O
4	23	own	JJ	O	I-NP	O
4	24	risk	NN	O	I-NP	O
4	25	because	IN	O	O	O
4	26	no	DT	O	B-NP	O
4	27	regulatory	JJ	O	I-NP	O
4	28	agency	NN	O	I-NP	B-OrgCorp
4	29	currently	RB	O	O	O
4	30	has	VBZ	O	B-VP	O
4	31	the	DT	O	B-NP	O
4	32	authority	NN	O	I-NP	O
4	33	to	TO	O	B-VP	O
4	34	assess	VB	O	I-VP	O
4	35	the	DT	O	B-NP	O
4	36	safety	NN	O	I-NP	O
4	37	COMMA	COMMA	O	O	O
4	38	purity	NN	O	B-NP	O
4	39	or	CC	O	I-NP	O
4	40	effectiveness	NN	O	I-NP	O
4	41	of	IN	O	B-PP	O
4	42	these	DT	O	B-NP	O
4	43	products	NNS	O	I-NP	O
4	44	before	IN	O	O	O
4	45	they	PRP	O	B-NP	O
4	46	can	MD	O	B-VP	O
4	47	be	VB	O	I-VP	O
4	48	sold	VBN	O	I-VP	O
4	49	to	TO	O	B-PP	O
4	50	the	DT	O	B-NP	O
4	51	public	NN	O	I-NP	O
4	52	.	.	O	O	O

5	0	Members	NNS	O	B-NP	O
5	1	of	IN	O	B-PP	O
5	2	the	DT	O	B-NP	O
5	3	public	NN	O	I-NP	O
5	4	may	MD	O	B-VP	O
5	5	be	VB	O	I-VP	O
5	6	COMMA	COMMA	O	O	O
5	7	in	IN	O	B-PP	O
5	8	effect	NN	O	B-NP	O
5	9	COMMA	COMMA	O	O	O
5	10	serving	VBG	O	B-VP	O
5	11	as	IN	O	B-PP	O
5	12	guinea	NN	O	O	B-Animal
5	13	pigs	NNS	O	O	I-Animal
5	14	in	IN	O	B-PP	O
5	15	experiments	NNS	O	B-NP	O
5	16	that	IN	O	B-NP	O
5	17	don	VB	O	B-VP	O
5	18	't	NN	O	B-NP	O
5	19	always	RB	O	O	O
5	20	have	VBP	O	B-VP	O
5	21	happy	JJ	O	B-NP	O
5	22	endings	NNS	O	I-NP	O
5	23	.	.	O	O	O

6	0	While	IN	O	O	O
6	1	the	DT	O	B-NP	O
6	2	majority	NN	O	I-NP	O
6	3	of	IN	O	B-PP	O
6	4	supplement	NN	O	B-NP	O
6	5	manufacturers	NNS	O	I-NP	B-ProfTitle
6	6	are	VBP	O	B-VP	O
6	7	scrupulous	JJ	O	O	O
6	8	and	CC	O	O	O
6	9	use	VBP	O	B-VP	O
6	10	production	NN	O	B-NP	O
6	11	techniques	NNS	O	I-NP	O
6	12	that	DT	O	B-NP	O
6	13	approach	VBP	O	B-VP	O
6	14	pharmaceutical	JJ	O	B-NP	B-Medical
6	15	standards	NNS	O	I-NP	O
6	16	COMMA	COMMA	O	O	O
6	17	others	NNS	O	B-NP	O
6	18	are	VBP	O	B-VP	O
6	19	less	JJR	O	B-NP	O
6	20	than	IN	O	B-PP	O
6	21	careful	JJ	O	O	O
6	22	and	CC	O	O	O
6	23	some	DT	O	B-NP	O
6	24	are	VBP	O	B-VP	O
6	25	downright	RB	O	O	O
6	26	cheats	VBZ	O	B-VP	O
6	27	COMMA	COMMA	O	O	O
6	28	filling	VBG	O	B-VP	O
6	29	capsules	NNS	O	B-NP	O
6	30	with	IN	O	B-PP	O
6	31	impure	JJ	O	B-NP	O
6	32	substances	NNS	O	I-NP	O
6	33	and	CC	O	O	O
6	34	sometimes	RB	O	O	O
6	35	with	IN	O	B-PP	O
6	36	little	JJ	O	B-NP	O
6	37	or	CC	O	I-NP	O
6	38	none	NN	O	I-NP	O
6	39	of	IN	O	B-PP	O
6	40	the	DT	O	B-NP	O
6	41	ingredients	NNS	O	I-NP	O
6	42	listed	VBN	O	B-VP	O
6	43	on	IN	O	B-PP	O
6	44	the	DT	O	B-NP	O
6	45	label	NN	O	I-NP	O
6	46	.	.	O	O	O

7	0	Once	RB	O	O	O
7	1	upon	IN	O	B-PP	O
7	2	a	DT	O	B-NP	O
7	3	time	NN	O	I-NP	O
7	4	COMMA	COMMA	O	O	O
7	5	dietary	JJ	O	B-NP	O
7	6	supplements	NNS	O	I-NP	O
7	7	of	IN	O	B-PP	O
7	8	all	DT	O	B-NP	O
7	9	kinds	NNS	O	I-NP	O
7	10	were	VBD	O	B-VP	O
7	11	treated	VBN	O	I-VP	O
7	12	as	IN	O	B-PP	O
7	13	food	NN	O	B-NP	B-Food
7	14	additives	NNS	O	I-NP	O
7	15	under	IN	O	B-PP	O
7	16	the	DT	O	B-NP	O
7	17	direct	JJ	O	I-NP	O
7	18	jurisdiction	NN	O	I-NP	O
7	19	of	IN	O	B-PP	O
7	20	the	DT	O	B-NP	O
7	21	Food	NNP	O	I-NP	B-Food
7	22	and	CC	O	I-NP	O
7	23	Drug	NNP	O	I-NP	B-Loc
7	24	Administration	NNP	O	I-NP	I-Loc
7	25	.	.	O	O	O

8	0	Producers	NNS	O	B-NP	B-ProfTitle
8	1	had	VBD	O	B-VP	O
8	2	to	TO	O	I-VP	O
8	3	prove	VB	O	I-VP	O
8	4	they	PRP	O	B-NP	O
8	5	were	VBD	O	B-VP	O
8	6	safe	JJ	O	O	O
8	7	before	IN	O	O	O
8	8	they	PRP	O	B-NP	O
8	9	could	MD	O	B-VP	O
8	10	be	VB	O	I-VP	O
8	11	sold	VBN	O	I-VP	O
8	12	COMMA	COMMA	O	O	O
8	13	a	DT	O	B-NP	O
8	14	requirement	NN	O	I-NP	O
8	15	that	WDT	O	B-NP	O
8	16	doubtless	RB	O	O	O
8	17	kept	VBD	O	B-VP	O
8	18	hundreds	NNS	O	B-NP	B-Num
8	19	of	IN	O	B-PP	O
8	20	products	NNS	O	B-NP	O
8	21	off	IN	O	B-PP	O
8	22	the	DT	O	B-NP	O
8	23	shelves	NNS	O	I-NP	O
8	24	.	.	O	O	O

9	0	Producers	NNS	O	B-NP	B-ProfTitle
9	1	also	RB	O	O	O
9	2	could	MD	O	B-VP	O
9	3	not	RB	O	I-VP	O
9	4	claim	VB	O	I-VP	O
9	5	any	DT	O	B-NP	O
9	6	health	NN	O	I-NP	O
9	7	benefits	NNS	O	I-NP	O
9	8	that	WDT	O	B-NP	O
9	9	were	VBD	O	B-VP	O
9	10	not	RB	O	I-VP	O
9	11	scientifically	RB	O	I-VP	O
9	12	established	VBN	O	I-VP	O
9	13	to	TO	O	B-PP	O
9	14	the	DT	O	B-NP	O
9	15	satisfaction	NN	O	I-NP	O
9	16	of	IN	O	B-PP	O
9	17	the	DT	O	B-NP	O
9	18	FDA	NNP	O	I-NP	B-Org
9	19	.	.	O	O	O

10	0	But	CC	O	O	O
10	1	in	IN	O	B-PP	O
10	2	1994	CD	O	B-NP	B-Date
10	3	COMMA	COMMA	O	O	O
10	4	under	IN	O	B-PP	O
10	5	a	DT	O	B-NP	O
10	6	deluge	NN	O	I-NP	O
10	7	of	IN	O	B-PP	O
10	8	consumer	NN	O	B-NP	O
10	9	pressure	NN	O	I-NP	O
10	10	instigated	VBD	O	B-VP	O
10	11	by	IN	O	B-PP	O
10	12	the	DT	O	B-NP	O
10	13	supplement	NN	O	I-NP	O
10	14	industry	NN	O	I-NP	O
10	15	COMMA	COMMA	O	O	O
10	16	Congress	NNP	O	B-NP	B-Peop
10	17	changed	VBD	O	B-VP	O
10	18	the	DT	O	B-NP	O
10	19	rules	NNS	O	I-NP	O
10	20	.	.	O	O	O

11	0	Dietary	JJ	O	O	O
11	1	supplements	NNS	O	O	O
11	2	_	NN	O	O	O
11	3	broadly	RB	O	B-VP	O
11	4	defined	VBN	O	I-VP	O
11	5	to	TO	O	B-VP	O
11	6	include	VB	O	I-VP	O
11	7	herbs	NNS	O	B-NP	O
11	8	COMMA	COMMA	O	O	O
11	9	amino	JJ	O	B-NP	O
11	10	acids	NNS	O	I-NP	O
11	11	COMMA	COMMA	O	O	O
11	12	botanical	JJ	O	B-NP	O
11	13	extracts	NNS	O	I-NP	O
11	14	COMMA	COMMA	O	O	O
11	15	quasi-vitamins	JJ	O	O	O
11	16	as	RB	O	O	O
11	17	well	RB	O	O	O
11	18	as	IN	O	O	O
11	19	real	JJ	O	B-NP	O
11	20	vitamins	NNS	O	I-NP	O
11	21	and	CC	O	I-NP	O
11	22	minerals	NNS	O	I-NP	O
11	23	_	NN	O	I-NP	O
11	24	could	MD	O	B-VP	O
11	25	be	VB	O	I-VP	O
11	26	sold	VBN	O	I-VP	O
11	27	without	IN	O	B-PP	O
11	28	any	DT	O	B-NP	O
11	29	prior	JJ	O	I-NP	O
11	30	approval	NN	O	I-NP	O
11	31	of	IN	O	B-PP	O
11	32	the	DT	O	B-NP	O
11	33	agency	NN	O	I-NP	B-OrgCorp
11	34	COMMA	COMMA	O	O	O
11	35	which	WDT	O	B-NP	O
11	36	had	VBD	O	B-VP	O
11	37	been	VBN	O	I-VP	O
11	38	established	VBN	O	O	O
11	39	decades	NNS	O	O	O
11	40	earlier	RB	O	O	O
11	41	to	TO	O	B-VP	O
11	42	safeguard	VB	O	I-VP	O
11	43	the	DT	O	B-NP	O
11	44	health	NN	O	I-NP	O
11	45	of	IN	O	B-PP	O
11	46	Americans	NNPS	O	B-NP	B-LangRace
11	47	against	IN	O	B-PP	O
11	48	the	DT	O	B-NP	O
11	49	onslaught	NN	O	I-NP	O
11	50	of	IN	O	B-PP	O
11	51	unethical	JJ	O	B-NP	O
11	52	or	CC	O	I-NP	O
11	53	careless	JJ	O	I-NP	O
11	54	food	NN	O	I-NP	B-Food
11	55	and	CC	O	I-NP	O
11	56	drug	NN	O	I-NP	B-Medical
11	57	producers	NNS	O	I-NP	B-ProfTitle
11	58	.	.	O	O	O

12	0	Now	RB	O	O	O
12	1	COMMA	COMMA	O	O	O
12	2	under	IN	O	B-PP	O
12	3	the	DT	O	B-NP	O
12	4	new	JJ	O	I-NP	O
12	5	law	NN	O	I-NP	O
12	6	entitled	VBD	O	B-VP	O
12	7	the	DT	O	B-NP	O
12	8	Dietary	NNP	O	I-NP	B-Org
12	9	Supplement	NNP	O	I-NP	I-Org
12	10	Health	NNP	O	I-NP	I-Org
12	11	and	CC	O	O	O
12	12	Education	NNP	O	B-NP	O
12	13	Act	NNP	O	I-NP	B-Event
12	14	COMMA	COMMA	O	O	O
12	15	it	PRP	O	B-NP	O
12	16	is	VBZ	O	B-VP	O
12	17	up	IN	O	B-PP	O
12	18	to	TO	O	B-PP	O
12	19	the	DT	O	B-NP	O
12	20	FDA	NNP	O	I-NP	B-Org
12	21	to	TO	O	B-VP	O
12	22	take	VB	O	I-VP	O
12	23	products	NNS	O	B-NP	O
12	24	off	IN	O	B-PP	O
12	25	the	DT	O	B-NP	O
12	26	market	NN	O	I-NP	O
12	27	only	RB	O	O	O
12	28	after	IN	O	O	O
12	29	they	PRP	O	B-NP	O
12	30	have	VBP	O	B-VP	O
12	31	proved	VBN	O	I-VP	O
12	32	dangerous	JJ	O	O	O
12	33	to	TO	O	B-PP	O
12	34	people	NNS	O	B-NP	O
12	35	taking	VBG	O	B-VP	O
12	36	them	PRP	O	B-NP	O
12	37	.	.	O	O	O

13	0	Only	RB	O	O	O
13	1	when	WRB	O	O	O
13	2	a	DT	O	B-NP	O
13	3	new	JJ	O	I-NP	O
13	4	ingredient	NN	O	I-NP	O
13	5	is	VBZ	O	B-VP	O
13	6	introduced	VBN	O	I-VP	O
13	7	is	VBZ	O	B-VP	O
13	8	the	DT	O	B-NP	O
13	9	company	NN	O	I-NP	B-OrgCorp
13	10	obliged	VBN	O	O	O
13	11	to	TO	O	B-VP	O
13	12	provide	VB	O	I-VP	O
13	13	the	DT	O	B-NP	O
13	14	drug	NN	O	I-NP	B-Medical
13	15	agency	NN	O	I-NP	B-OrgCorp
13	16	with	IN	O	B-PP	O
13	17	documentation	NN	O	B-NP	O
13	18	of	IN	O	B-PP	O
13	19	its	PP$	O	B-NP	O
13	20	presumed	VBN	O	I-NP	O
13	21	safety	NN	O	I-NP	O
13	22	.	.	O	O	O

14	0	Furthermore	RB	O	O	O
14	1	COMMA	COMMA	O	O	O
14	2	while	IN	O	O	O
14	3	companies	NNS	O	B-NP	B-OrgCorp
14	4	cannot	NN	O	B-NP	O
14	5	make	VBP	O	B-VP	O
14	6	claims	NNS	O	B-NP	O
14	7	of	IN	O	B-PP	O
14	8	a	DT	O	B-NP	O
14	9	product	NN	O	I-NP	O
14	10	's	POS	O	B-NP	O
14	11	ability	NN	O	I-NP	O
14	12	to	TO	O	B-VP	O
14	13	treat	VB	O	I-VP	O
14	14	or	CC	O	I-VP	O
14	15	prevent	VB	O	I-VP	O
14	16	disease	NN	O	B-NP	B-Medical
14	17	COMMA	COMMA	O	O	O
14	18	they	PRP	O	B-NP	O
14	19	can	MD	O	B-VP	O
14	20	make	VB	O	I-VP	O
14	21	general	JJ	O	B-NP	B-ProfTitle
14	22	function	NN	O	I-NP	O
14	23	COMMA	COMMA	O	O	O
14	24	wellness	NN	O	B-NP	O
14	25	and	CC	O	I-NP	O
14	26	nutritional	JJ	O	I-NP	O
14	27	support	VBP	O	B-VP	O
14	28	statements	NNS	O	B-NP	O
14	29	on	IN	O	B-PP	O
14	30	package	NN	O	B-NP	O
14	31	labels	NNS	O	I-NP	O
14	32	that	IN	O	O	O
14	33	imply	VBP	O	B-VP	O
14	34	health	NN	O	B-NP	O
14	35	benefits	NNS	O	I-NP	O
14	36	COMMA	COMMA	O	O	O
14	37	even	RB	O	O	O
14	38	though	IN	O	O	O
14	39	such	JJ	O	B-NP	O
14	40	benefits	NNS	O	I-NP	O
14	41	may	MD	O	B-VP	O
14	42	not	RB	O	I-VP	O
14	43	be	VB	O	I-VP	O
14	44	well	RB	O	O	O
14	45	established	VBN	O	O	O
14	46	by	IN	O	B-PP	O
14	47	properly	RB	O	O	O
14	48	designed	VBN	O	O	O
14	49	scientific	JJ	O	B-NP	O
14	50	experiments	NNS	O	I-NP	O
14	51	.	.	O	O	O

15	0	Thus	RB	O	O	O
15	1	COMMA	COMMA	O	O	O
15	2	an	DT	O	B-NP	O
15	3	herb	NN	O	I-NP	O
15	4	called	VBN	O	B-VP	O
15	5	saw	VBD	O	B-VP	O
15	6	palmetto	NN	O	B-NP	O
15	7	can	MD	O	B-VP	O
15	8	be	VB	O	I-VP	O
15	9	said	VBD	O	I-VP	O
15	10	to	TO	O	I-VP	O
15	11	promote	VB	O	I-VP	O
15	12	prostate	NN	O	B-NP	B-Jour
15	13	health	NN	O	I-NP	O
15	14	and	CC	O	I-NP	O
15	15	ginkgo	NN	O	I-NP	O
15	16	to	TO	O	B-VP	O
15	17	enhance	VB	O	I-VP	O
15	18	memory	NN	O	B-NP	O
15	19	.	.	O	O	O

16	0	And	CC	O	O	O
16	1	while	IN	O	O	O
16	2	people	NNS	O	B-NP	O
16	3	have	VBP	O	B-VP	O
16	4	long	RB	O	I-VP	O
16	5	used	VBD	O	I-VP	O
16	6	the	DT	O	B-NP	O
16	7	herb	NN	O	I-NP	O
16	8	feverfew	NN	O	I-NP	O
16	9	to	TO	O	B-VP	O
16	10	help	VB	O	I-VP	O
16	11	with	IN	O	B-PP	O
16	12	migraine	NN	O	B-NP	B-Medical
16	13	headaches	NNS	O	I-NP	O
16	14	COMMA	COMMA	O	O	O
16	15	producers	NNS	O	B-NP	B-ProfTitle
16	16	can	MD	O	B-VP	O
16	17	only	RB	O	I-VP	O
16	18	say	VB	O	I-VP	O
16	19	it	PRP	O	B-NP	O
16	20	helps	VBZ	O	B-VP	O
16	21	with	IN	O	B-PP	O
16	22	brain	NN	O	B-NP	O
16	23	function	NN	O	I-NP	O
16	24	.	.	O	O	O

17	0	But	CC	O	O	O
17	1	not	RB	O	O	O
17	2	every	DT	O	B-NP	O
17	3	consumer	NN	O	I-NP	O
17	4	organization	NN	O	I-NP	O
17	5	supported	VBD	O	B-VP	O
17	6	the	DT	O	B-NP	O
17	7	new	JJ	O	I-NP	O
17	8	law	NN	O	I-NP	O
17	9	.	.	O	O	O

18	0	For	IN	O	B-PP	O
18	1	example	NN	O	B-NP	O
18	2	COMMA	COMMA	O	O	O
18	3	the	DT	O	B-NP	O
18	4	Washington-based	JJ	O	I-NP	B-OrgCorp
18	5	Center	NNP	O	I-NP	B-LocStruct
18	6	for	IN	O	B-PP	O
18	7	Science	NNP	O	B-NP	B-Loc
18	8	in	IN	O	B-PP	O
18	9	the	DT	O	B-NP	O
18	10	Public	NNP	O	I-NP	B-Org
18	11	Interest	NNP	O	I-NP	I-Org
18	12	COMMA	COMMA	O	O	O
18	13	a	DT	O	B-NP	O
18	14	nonprofit	JJ	O	I-NP	O
18	15	consumer	NN	O	I-NP	O
18	16	advocacy	NN	O	I-NP	O
18	17	group	NN	O	I-NP	B-OrgCorp
18	18	COMMA	COMMA	O	O	O
18	19	called	VBD	O	B-VP	O
18	20	the	DT	O	B-NP	O
18	21	bill	NN	O	I-NP	O
18	22	a	DT	O	B-NP	O
18	23	``	``	O	I-NP	O
18	24	ticking	VBG	O	I-NP	O
18	25	time	NN	O	I-NP	O
18	26	bomb	NN	O	I-NP	O
18	27	''	''	O	O	O
18	28	that	IN	O	B-NP	O
18	29	would	MD	O	B-VP	O
18	30	force	VB	O	I-VP	O
18	31	consumers	NNS	O	B-NP	O
18	32	to	TO	O	B-VP	O
18	33	``	``	O	I-VP	O
18	34	play	VBP	O	I-VP	O
18	35	Russian	JJ	O	B-NP	B-LangRace
18	36	roulette	NN	O	I-NP	O
18	37	when	WRB	O	O	O
18	38	they	PRP	O	B-NP	O
18	39	take	VBP	O	B-VP	O
18	40	a	DT	O	B-NP	O
18	41	supplement	NN	O	I-NP	O
18	42	.	.	O	O	O
18	43	''	''	O	O	O

19	0	The	DT	O	B-NP	O
19	1	center	NN	O	I-NP	O
19	2	pointed	VBD	O	B-VP	O
19	3	out	IN	O	O	O
19	4	that	DT	O	B-NP	O
19	5	royal	JJ	O	I-NP	O
19	6	jelly	NN	O	I-NP	O
19	7	COMMA	COMMA	O	O	O
19	8	a	DT	O	B-NP	O
19	9	dietary	JJ	O	I-NP	O
19	10	supplement	NN	O	I-NP	O
19	11	derived	VBN	O	B-VP	O
19	12	from	IN	O	B-PP	O
19	13	honey	NN	O	B-NP	O
19	14	bees	NNS	O	I-NP	B-Animal
19	15	COMMA	COMMA	O	O	O
19	16	had	VBD	O	B-VP	O
19	17	already	RB	O	I-VP	O
19	18	been	VBN	O	I-VP	O
19	19	linked	VBN	O	I-VP	O
19	20	to	TO	O	B-PP	O
19	21	the	DT	O	B-NP	O
19	22	death	NN	O	I-NP	O
19	23	of	IN	O	B-PP	O
19	24	an	DT	O	B-NP	O
19	25	11-year-old	JJ	O	I-NP	B-Num
19	26	girl	NN	O	I-NP	O
19	27	with	IN	O	B-PP	O
19	28	asthma	NN	O	B-NP	B-Medical
19	29	and	CC	O	O	O
19	30	had	VBD	O	B-VP	O
19	31	caused	VBN	O	I-VP	O
19	32	serious	JJ	O	B-NP	O
19	33	asthmatic	JJ	O	I-NP	O
19	34	attacks	NNS	O	I-NP	O
19	35	in	IN	O	B-PP	O
19	36	nine	CD	O	B-NP	B-Num
19	37	other	JJ	O	I-NP	O
19	38	people	NNS	O	I-NP	O
19	39	.	.	O	O	O

20	0	In	IN	O	B-PP	O
20	1	the	DT	O	B-NP	O
20	2	newly	RB	O	I-NP	O
20	3	published	VBN	O	I-NP	O
20	4	reports	NNS	O	I-NP	O
20	5	COMMA	COMMA	O	O	O
20	6	researchers	NNS	O	B-NP	B-ProfTitle
20	7	described	VBD	O	B-VP	O
20	8	PC-SPES	NNP	O	B-NP	B-OrgCorp
20	9	COMMA	COMMA	O	O	O
20	10	an	DT	O	B-NP	O
20	11	unregulated	JJ	O	I-NP	O
20	12	mixture	NN	O	I-NP	O
20	13	of	IN	O	B-PP	O
20	14	herbs	NNS	O	B-NP	O
20	15	with	IN	O	B-PP	O
20	16	potent	JJ	O	B-NP	O
20	17	estrogen-like	JJ	O	I-NP	O
20	18	activity	NN	O	I-NP	O
20	19	COMMA	COMMA	O	O	O
20	20	that	IN	O	B-NP	O
20	21	caused	VBN	O	B-VP	O
20	22	serious	JJ	O	B-NP	O
20	23	side	NN	O	I-NP	O
20	24	effects	NNS	O	I-NP	O
20	25	in	IN	O	B-PP	O
20	26	patients	NNS	O	B-NP	O
20	27	with	IN	O	B-PP	O
20	28	prostate	NN	O	B-NP	B-Jour
20	29	cancer	NN	O	I-NP	B-Medical
20	30	.	.	O	O	O

21	0	In	IN	O	B-PP	O
21	1	another	DT	O	B-NP	O
21	2	report	NN	O	I-NP	O
21	3	COMMA	COMMA	O	O	O
21	4	two	CD	O	B-NP	B-Num
21	5	previously	RB	O	I-NP	O
21	6	healthy	JJ	O	I-NP	O
21	7	young	JJ	O	I-NP	O
21	8	women	NNS	O	I-NP	O
21	9	were	VBD	O	B-VP	O
21	10	said	VBN	O	I-VP	O
21	11	to	TO	O	I-VP	O
21	12	have	VB	O	I-VP	O
21	13	suffered	VBN	O	I-VP	O
21	14	irregular	JJ	O	B-NP	O
21	15	heart	NN	O	I-NP	B-Medical
21	16	rhythms	NN	O	I-NP	O
21	17	COMMA	COMMA	O	O	O
21	18	lethargy	NN	O	B-NP	B-Medical
21	19	COMMA	COMMA	O	O	O
21	20	persistent	JJ	O	B-NP	O
21	21	nausea	NN	O	I-NP	B-Medical
21	22	and	CC	O	O	O
21	23	severe	JJ	O	B-NP	O
21	24	vomiting	NN	O	I-NP	B-Medical
21	25	after	IN	O	B-PP	O
21	26	taking	VBG	O	B-VP	O
21	27	a	DT	O	B-NP	O
21	28	botanical	JJ	O	I-NP	O
21	29	dietary	JJ	O	I-NP	O
21	30	supplement	NN	O	I-NP	O
21	31	that	WDT	O	B-NP	O
21	32	was	VBD	O	B-VP	O
21	33	contaminated	JJ	O	O	O
21	34	with	IN	O	B-PP	O
21	35	digitalis	NN	O	B-NP	O
21	36	COMMA	COMMA	O	O	O
21	37	a	DT	O	B-NP	O
21	38	drug	NN	O	I-NP	B-Medical
21	39	that	WDT	O	B-NP	O
21	40	could	MD	O	B-VP	O
21	41	provoke	VB	O	I-VP	O
21	42	fatal	JJ	O	B-NP	B-Medical
21	43	heart	NN	O	I-NP	B-Medical
21	44	rhythms	NN	O	I-NP	O
21	45	when	WRB	O	O	O
21	46	inappropriately	RB	O	O	O
21	47	used	VBN	O	O	O
21	48	.	.	O	O	O

22	0	Another	DT	O	B-NP	O
22	1	report	NN	O	I-NP	O
22	2	told	VBD	O	B-VP	O
22	3	of	IN	O	B-PP	O
22	4	two	CD	O	B-NP	B-Num
22	5	children	NNS	O	I-NP	O
22	6	with	IN	O	B-PP	O
22	7	cancer	NN	O	B-NP	B-Medical
22	8	whose	WP$	O	B-NP	O
22	9	parents	NNS	O	I-NP	O
22	10	rejected	VBD	O	B-VP	O
22	11	established	VBN	O	I-VP	O
22	12	chemotherapy	NN	O	B-NP	B-Jour
22	13	for	IN	O	B-PP	O
22	14	dietary	JJ	O	B-NP	O
22	15	supplements	NNS	O	I-NP	O
22	16	_	NN	O	I-NP	O
22	17	a	DT	O	B-NP	O
22	18	botanical	JJ	O	I-NP	O
22	19	said	VBD	O	B-VP	O
22	20	to	TO	O	I-VP	O
22	21	boost	VB	O	I-VP	O
22	22	immunity	NN	O	B-NP	B-Jour
22	23	in	IN	O	B-PP	O
22	24	one	CD	O	B-NP	B-Num
22	25	case	NN	O	I-NP	O
22	26	and	CC	O	O	O
22	27	shark	NN	O	O	B-Animal
22	28	cartilage	NN	O	O	O
22	29	-LBR-	-LBR-	O	O	O
22	30	a	DT	O	B-NP	O
22	31	supplement	NN	O	I-NP	O
22	32	popularized	VBD	O	B-VP	O
22	33	by	IN	O	B-PP	O
22	34	the	DT	O	B-NP	O
22	35	1992	CD	O	I-NP	B-Date
22	36	book	NN	O	I-NP	B-Book
22	37	``	``	O	O	O
22	38	Sharks	NNP	O	B-NP	B-OrgTeam
22	39	Don	NNP	O	I-NP	B-Peop
22	40	't	NN	O	I-NP	O
22	41	Get	VBP	O	B-VP	O
22	42	Cancer	NNP	O	O	O
22	43	''	''	O	O	O
22	44	-RBR-	-RBR-	O	O	O
22	45	in	IN	O	B-PP	O
22	46	the	DT	O	B-NP	O
22	47	other	JJ	O	I-NP	O
22	48	.	.	O	O	O

23	0	One	CD	O	B-NP	B-Num
23	1	child	NN	O	I-NP	O
23	2	died	VBD	O	B-VP	O
23	3	in	IN	O	B-PP	O
23	4	a	DT	O	B-NP	O
23	5	few	JJ	O	I-NP	O
23	6	months	NNS	O	I-NP	B-Date
23	7	COMMA	COMMA	O	O	O
23	8	the	DT	O	B-NP	O
23	9	other	JJ	O	I-NP	O
23	10	developed	VBD	O	B-VP	O
23	11	a	DT	O	O	O
23	12	more	JJR	O	O	O
23	13	advanced	VBD	O	B-VP	O
23	14	cancer	NN	O	B-NP	B-Medical
23	15	requiring	VBG	O	B-VP	O
23	16	more	RBR	O	B-NP	O
23	17	potent	JJ	O	I-NP	O
23	18	therapy	NN	O	I-NP	B-Medical
23	19	.	.	O	O	O

24	0	In	IN	O	B-PP	O
24	1	still	RB	O	B-NP	O
24	2	another	DT	O	I-NP	O
24	3	report	NN	O	I-NP	O
24	4	COMMA	COMMA	O	O	O
24	5	an	DT	O	B-NP	O
24	6	analysis	NN	O	I-NP	B-Medical
24	7	of	IN	O	B-PP	O
24	8	260	CD	O	B-NP	B-Num
24	9	Asian	JJ	O	I-NP	B-LangRace
24	10	patent	NN	O	I-NP	O
24	11	medicines	NNS	O	I-NP	O
24	12	sold	VBN	O	B-VP	O
24	13	in	IN	O	B-PP	O
24	14	California	NNP	O	B-NP	B-LocStat
24	15	revealed	VBD	O	B-VP	O
24	16	that	IN	O	O	O
24	17	32	CD	O	B-NP	B-NumPercent
24	18	percent	NN	O	I-NP	I-NumPercent
24	19	contained	VBD	O	B-VP	O
24	20	a	DT	O	B-NP	O
24	21	drug	NN	O	I-NP	B-Medical
24	22	not	RB	O	B-VP	O
24	23	listed	VBD	O	I-VP	O
24	24	on	IN	O	B-PP	O
24	25	the	DT	O	B-NP	O
24	26	label	NN	O	I-NP	O
24	27	or	CC	O	I-NP	O
24	28	contaminants	NNS	O	I-NP	O
24	29	like	VBP	O	B-VP	O
24	30	lead	NN	O	B-NP	O
24	31	COMMA	COMMA	O	O	O
24	32	arsenic	NN	O	B-NP	O
24	33	and	CC	O	I-NP	O
24	34	mercury	NN	O	I-NP	O
24	35	.	.	O	O	O

25	0	Dr.	NNP	O	B-NP	B-ProfTitle
25	1	Lori	NNP	O	I-NP	B-Peop
25	2	Love	NNP	O	I-NP	I-Peop
25	3	and	CC	O	O	O
25	4	colleagues	NNS	O	B-NP	O
25	5	at	IN	O	B-PP	O
25	6	the	DT	O	B-NP	O
25	7	FDA	NNP	O	I-NP	B-Org
25	8	pointed	VBD	O	B-VP	O
25	9	out	IN	O	O	O
25	10	in	IN	O	B-PP	O
25	11	the	DT	O	B-NP	O
25	12	journal	NN	O	I-NP	B-Jour
25	13	that	IN	O	O	O
25	14	``	``	O	O	O
25	15	there	EX	O	B-NP	O
25	16	are	VBP	O	B-VP	O
25	17	currently	RB	O	O	O
25	18	no	DT	O	B-NP	O
25	19	federal	JJ	O	I-NP	O
25	20	regulations	NNS	O	I-NP	O
25	21	that	IN	O	B-NP	O
25	22	establish	VBP	O	B-VP	O
25	23	specific	JJ	O	B-NP	O
25	24	criteria	NNS	O	I-NP	O
25	25	for	IN	O	B-PP	O
25	26	purity	NN	O	B-NP	O
25	27	COMMA	COMMA	O	I-NP	O
25	28	identification	NN	O	I-NP	B-Medical
25	29	and	CC	O	I-NP	O
25	30	manufacturing	NN	O	I-NP	O
25	31	procedures	NNS	O	I-NP	O
25	32	of	IN	O	B-PP	O
25	33	dietary	JJ	O	B-NP	O
25	34	supplements	NNS	O	I-NP	O
25	35	.	.	O	O	O
25	36	''	''	O	O	O

26	0	In	IN	O	B-PP	O
26	1	other	JJ	O	B-NP	O
26	2	words	NNS	O	I-NP	O
26	3	COMMA	COMMA	O	O	O
26	4	producers	NNS	O	B-NP	B-ProfTitle
26	5	can	MD	O	B-VP	O
26	6	put	VB	O	I-VP	O
26	7	in	IN	O	B-PP	O
26	8	just	RB	O	O	O
26	9	about	IN	O	O	O
26	10	anything	NN	O	B-NP	O
26	11	they	PRP	O	B-NP	O
26	12	want	VBP	O	B-VP	O
26	13	COMMA	COMMA	O	O	O
26	14	including	VBG	O	B-PP	O
26	15	no	DT	O	B-NP	O
26	16	active	JJ	O	I-NP	O
26	17	ingredient	NN	O	I-NP	O
26	18	at	IN	O	O	O
26	19	all	DT	O	O	O
26	20	COMMA	COMMA	O	O	O
26	21	and	CC	O	O	O
26	22	there	EX	O	B-NP	O
26	23	is	VBZ	O	B-VP	O
26	24	no	DT	O	B-NP	O
26	25	guarantee	NN	O	I-NP	O
26	26	that	IN	O	O	O
26	27	what	WP	O	B-NP	O
26	28	it	PRP	O	B-NP	O
26	29	says	VBZ	O	B-VP	O
26	30	on	IN	O	B-PP	O
26	31	the	DT	O	B-NP	O
26	32	label	NN	O	I-NP	O
26	33	is	VBZ	O	B-VP	O
26	34	what	WP	O	B-NP	O
26	35	is	VBZ	O	B-VP	O
26	36	in	IN	O	B-PP	O
26	37	the	DT	O	B-NP	O
26	38	bottle	NN	O	I-NP	O
26	39	.	.	O	O	O

27	0	An	DT	O	B-NP	O
27	1	analysis	NN	O	I-NP	B-Medical
27	2	of	IN	O	B-PP	O
27	3	ginseng	NN	O	B-NP	O
27	4	products	NNS	O	I-NP	O
27	5	COMMA	COMMA	O	O	O
27	6	for	IN	O	B-PP	O
27	7	example	NN	O	B-NP	O
27	8	COMMA	COMMA	O	O	O
27	9	revealed	VBD	O	B-VP	O
27	10	up	IN	O	O	O
27	11	to	TO	O	B-PP	O
27	12	a	DT	O	B-NP	O
27	13	10-fold	JJ	O	I-NP	B-Num
27	14	difference	NN	O	I-NP	O
27	15	in	IN	O	B-PP	O
27	16	the	DT	O	B-NP	O
27	17	amount	NN	O	I-NP	O
27	18	of	IN	O	B-PP	O
27	19	the	DT	O	B-NP	O
27	20	active	JJ	O	I-NP	O
27	21	ingredient	NN	O	I-NP	O
27	22	COMMA	COMMA	O	O	O
27	23	even	RB	O	O	O
27	24	though	IN	O	O	O
27	25	all	DT	O	B-NP	O
27	26	were	VBD	O	B-VP	O
27	27	labeled	VBN	O	I-VP	O
27	28	as	IN	O	B-PP	O
27	29	containing	VBG	O	B-VP	O
27	30	the	DT	O	B-NP	O
27	31	same	JJ	O	I-NP	O
27	32	amount	NN	O	I-NP	O
27	33	.	.	O	O	O

28	0	Nor	CC	O	O	O
28	1	is	VBZ	O	O	O
28	2	the	DT	O	B-NP	O
28	3	producer	NN	O	I-NP	B-ProfTitle
28	4	required	VBD	O	B-VP	O
28	5	to	TO	O	I-VP	O
28	6	maintain	VB	O	I-VP	O
28	7	pharmaceutical	JJ	O	B-NP	B-Medical
28	8	standards	NNS	O	I-NP	O
28	9	in	IN	O	B-PP	O
28	10	making	VBG	O	B-VP	O
28	11	the	DT	O	B-NP	O
28	12	product	NN	O	I-NP	O
28	13	COMMA	COMMA	O	O	O
28	14	which	WDT	O	B-NP	O
28	15	could	MD	O	B-VP	O
28	16	end	VB	O	I-VP	O
28	17	up	IN	O	O	O
28	18	_	NN	O	B-NP	O
28	19	and	CC	O	O	O
28	20	some	DT	O	B-NP	O
28	21	have	VBP	O	B-VP	O
28	22	ended	VBN	O	I-VP	O
28	23	up	IN	O	O	O
28	24	_	NN	O	B-NP	O
28	25	with	IN	O	B-PP	O
28	26	all	DT	O	B-NP	O
28	27	manner	NN	O	I-NP	O
28	28	of	IN	O	B-PP	O
28	29	contaminants	NNS	O	B-NP	O
28	30	.	.	O	O	O

29	0	In	IN	O	B-PP	O
29	1	1990	CD	O	B-NP	B-Date
29	2	COMMA	COMMA	O	O	O
29	3	36	CD	O	B-NP	B-Num
29	4	people	NNS	O	I-NP	O
29	5	died	VBD	O	B-VP	O
29	6	and	CC	O	O	O
29	7	at	IN	O	B-NP	O
29	8	least	JJS	O	I-NP	O
29	9	1COMMA500	CD	O	I-NP	B-Num
29	10	became	VBD	O	B-VP	O
29	11	seriously	RB	O	O	O
29	12	ill	JJ	O	O	O
29	13	after	IN	O	B-PP	O
29	14	taking	VBG	O	B-VP	O
29	15	a	DT	O	B-NP	O
29	16	popular	JJ	O	I-NP	O
29	17	supplement	NN	O	I-NP	O
29	18	COMMA	COMMA	O	O	O
29	19	L-tryptophan	NNP	O	B-NP	O
29	20	COMMA	COMMA	O	O	O
29	21	which	WDT	O	B-NP	O
29	22	was	VBD	O	B-VP	O
29	23	subsequently	RB	O	I-VP	O
29	24	found	VBD	O	I-VP	O
29	25	to	TO	O	I-VP	O
29	26	contain	VB	O	I-VP	O
29	27	63	CD	O	B-NP	B-Num
29	28	contaminants	NNS	O	I-NP	O
29	29	and	CC	O	O	O
29	30	pulled	VBD	O	B-VP	O
29	31	from	IN	O	B-PP	O
29	32	the	DT	O	B-NP	O
29	33	market	NN	O	I-NP	O
29	34	.	.	O	O	O

30	0	Furthermore	RB	O	O	O
30	1	COMMA	COMMA	O	O	O
30	2	the	DT	O	B-NP	O
30	3	drug	NN	O	I-NP	B-Medical
30	4	agency	NN	O	I-NP	B-OrgCorp
30	5	researchers	NNS	O	I-NP	B-ProfTitle
30	6	noted	VBD	O	B-VP	O
30	7	COMMA	COMMA	O	O	O
30	8	``	``	O	O	O
30	9	there	EX	O	B-NP	O
30	10	are	VBP	O	B-VP	O
30	11	no	DT	O	B-NP	O
30	12	requirements	NNS	O	I-NP	O
30	13	for	IN	O	B-PP	O
30	14	mandatory	JJ	O	B-NP	O
30	15	reporting	NN	O	I-NP	O
30	16	to	TO	O	B-PP	O
30	17	the	DT	O	B-NP	O
30	18	FDA	NNP	O	I-NP	O
30	19	of	IN	O	B-PP	O
30	20	adverse	JJ	O	B-NP	B-Medical
30	21	events	NNS	O	I-NP	B-Event
30	22	by	IN	O	B-PP	O
30	23	the	DT	O	B-NP	O
30	24	manufacturer	NN	O	I-NP	B-ProfTitle
30	25	or	CC	O	I-NP	O
30	26	distributor	NN	O	I-NP	B-ProfTitle
30	27	of	IN	O	B-PP	O
30	28	these	DT	O	B-NP	O
30	29	productsCOMMA	NN	O	I-NP	O
30	30	''	''	O	O	O
30	31	which	WDT	O	B-NP	O
30	32	means	VBZ	O	B-VP	O
30	33	it	PRP	O	B-NP	O
30	34	is	VBZ	O	B-VP	O
30	35	up	IN	O	B-PP	O
30	36	to	TO	O	B-PP	O
30	37	the	DT	O	B-NP	O
30	38	agency	NN	O	I-NP	B-OrgCorp
30	39	and	CC	O	I-NP	O
30	40	physicians	NNS	O	I-NP	B-ProfTitle
30	41	to	TO	O	B-VP	O
30	42	pick	VB	O	I-VP	O
30	43	them	PRP	O	B-NP	O
30	44	up	IN	O	O	O
30	45	.	.	O	O	O

31	0	This	DT	O	B-NP	O
31	1	brings	VBZ	O	B-VP	O
31	2	up	IN	O	O	O
31	3	a	DT	O	B-NP	O
31	4	third	JJ	O	I-NP	B-Num
31	5	problem	NN	O	I-NP	O
31	6	:	:	O	O	O
31	7	Many	JJ	O	B-NP	O
31	8	COMMA	COMMA	O	O	O
31	9	perhaps	RB	O	O	O
31	10	most	JJS	O	O	O
31	11	COMMA	COMMA	O	O	O
31	12	people	NNS	O	B-NP	O
31	13	who	WP	O	B-NP	O
31	14	take	VBP	O	B-VP	O
31	15	over-the-counter	JJ	O	B-NP	O
31	16	dietary	JJ	O	I-NP	O
31	17	supplements	NNS	O	I-NP	O
31	18	and	CC	O	O	O
31	19	other	JJ	O	B-NP	O
31	20	alternative	NN	O	I-NP	B-Medical
31	21	remedies	NNS	O	I-NP	O
31	22	never	RB	O	O	O
31	23	report	VBP	O	B-VP	O
31	24	that	DT	O	B-NP	O
31	25	fact	NN	O	I-NP	O
31	26	to	TO	O	B-PP	O
31	27	their	PP$	O	B-NP	O
31	28	physicians	NNS	O	I-NP	B-ProfTitle
31	29	.	.	O	O	O

32	0	Even	RB	O	O	O
32	1	when	WRB	O	O	O
32	2	patients	NNS	O	B-NP	O
32	3	suffer	VBP	O	B-VP	O
32	4	untoward	NN	O	B-NP	O
32	5	effects	NNS	O	I-NP	O
32	6	COMMA	COMMA	O	O	O
32	7	they	PRP	O	B-NP	O
32	8	may	MD	O	B-VP	O
32	9	be	VB	O	I-VP	O
32	10	too	RB	O	O	O
32	11	embarrassed	VBD	O	B-VP	O
32	12	to	TO	O	I-VP	O
32	13	tell	VB	O	I-VP	O
32	14	their	PP$	O	B-NP	O
32	15	doctors	NNS	O	I-NP	B-ProfTitle
32	16	what	WP	O	B-NP	O
32	17	they	PRP	O	B-NP	O
32	18	had	VBD	O	B-VP	O
32	19	been	VBN	O	I-VP	O
32	20	taking	VBG	O	I-VP	O
32	21	.	.	O	O	O

33	0	As	IN	O	B-PP	O
33	1	a	DT	O	B-NP	O
33	2	result	NN	O	I-NP	O
33	3	COMMA	COMMA	O	O	O
33	4	doctors	NNS	O	B-NP	B-ProfTitle
33	5	sometimes	RB	O	O	O
33	6	mistakenly	RB	O	O	O
33	7	attribute	VBP	O	O	O
33	8	supplement-caused	JJ	O	B-NP	O
33	9	symptoms	NNS	O	I-NP	O
33	10	to	TO	O	B-PP	O
33	11	the	DT	O	B-NP	O
33	12	illness	NN	O	I-NP	O
33	13	or	CC	O	O	O
33	14	the	DT	O	B-NP	O
33	15	treatment	NN	O	I-NP	O
33	16	they	PRP	O	B-NP	O
33	17	prescribed	VBN	O	O	O
33	18	COMMA	COMMA	O	O	O
33	19	which	WDT	O	B-NP	O
33	20	can	MD	O	B-VP	O
33	21	result	VB	O	I-VP	O
33	22	in	IN	O	B-PP	O
33	23	unwarranted	JJ	O	B-NP	O
33	24	and	CC	O	I-NP	O
33	25	hazardous	JJ	O	I-NP	O
33	26	changes	NNS	O	I-NP	O
33	27	in	IN	O	B-PP	O
33	28	the	DT	O	B-NP	O
33	29	patient	NN	O	I-NP	B-Medical
33	30	's	POS	O	B-NP	O
33	31	medical	JJ	O	I-NP	O
33	32	care	NN	O	I-NP	O
33	33	.	.	O	O	O

34	0	In	IN	O	B-PP	O
34	1	an	DT	O	B-NP	O
34	2	accompanying	VBG	O	I-NP	O
34	3	editorial	NN	O	I-NP	O
34	4	COMMA	COMMA	O	O	O
34	5	Dr.	NNP	O	B-NP	B-ProfTitle
34	6	Marcia	NNP	O	I-NP	B-Peop
34	7	Angell	NNP	O	I-NP	I-Peop
34	8	and	CC	O	O	O
34	9	Dr.	NNP	O	B-NP	B-ProfTitle
34	10	Jerome	NNP	O	I-NP	B-Peop
34	11	Kassirer	NNP	O	I-NP	I-Peop
34	12	pointed	VBD	O	B-VP	O
34	13	out	IN	O	O	O
34	14	that	IN	O	O	O
34	15	consumers	NNS	O	B-NP	O
34	16	mistakenly	RB	O	O	O
34	17	assume	VBP	O	O	O
34	18	that	IN	O	O	O
34	19	dietary	JJ	O	B-NP	O
34	20	supplements	NNS	O	I-NP	O
34	21	are	VBP	O	B-VP	O
34	22	safer	JJR	O	O	O
34	23	than	IN	O	B-PP	O
34	24	drugs	NNS	O	B-NP	O
34	25	even	RB	O	O	O
34	26	though	IN	O	O	O
34	27	their	PP$	O	O	O
34	28	producers	NNS	O	B-NP	B-ProfTitle
34	29	often	RB	O	O	O
34	30	assert	VBP	O	B-VP	O
34	31	that	IN	O	O	O
34	32	they	PRP	O	B-NP	O
34	33	are	VBP	O	B-VP	O
34	34	as	IN	O	O	O
34	35	or	CC	O	O	O
34	36	more	RBR	O	O	O
34	37	powerful	JJ	O	O	O
34	38	than	IN	O	B-PP	O
34	39	conventional	JJ	O	B-NP	O
34	40	medicines	NNS	O	I-NP	O
34	41	.	.	O	O	O

35	0	But	CC	O	O	O
35	1	there	EX	O	B-NP	O
35	2	is	VBZ	O	B-VP	O
35	3	no	DT	O	B-NP	O
35	4	free	JJ	O	I-NP	O
35	5	lunch	NN	O	I-NP	O
35	6	.	.	O	O	O

36	0	If	IN	O	O	O
36	1	a	DT	O	B-NP	O
36	2	substance	NN	O	I-NP	O
36	3	contains	VBZ	O	B-VP	O
36	4	biologically	RB	O	B-NP	O
36	5	active	JJ	O	I-NP	O
36	6	ingredients	NNS	O	I-NP	O
36	7	COMMA	COMMA	O	O	O
36	8	it	PRP	O	B-NP	O
36	9	is	VBZ	O	B-VP	O
36	10	bound	VBN	O	I-VP	O
36	11	to	TO	O	I-VP	O
36	12	have	VB	O	I-VP	O
36	13	other	JJ	O	B-NP	O
36	14	effects	NNS	O	I-NP	O
36	15	that	WDT	O	B-NP	O
36	16	may	MD	O	B-VP	O
36	17	be	VB	O	I-VP	O
36	18	undesirable	JJ	O	O	O
36	19	COMMA	COMMA	O	O	O
36	20	even	RB	O	O	O
36	21	dangerous	JJ	O	O	O
36	22	.	.	O	O	O

37	0	The	DT	O	B-NP	O
37	1	editors	NNS	O	I-NP	B-ProfTitle
37	2	called	VBN	O	B-VP	O
37	3	for	IN	O	B-PP	O
37	4	rigorous	JJ	O	B-NP	O
37	5	testing	NN	O	I-NP	O
37	6	of	IN	O	B-PP	O
37	7	all	DT	O	B-NP	O
37	8	products	NNS	O	I-NP	O
37	9	COMMA	COMMA	O	O	O
37	10	stating	VBG	O	B-VP	O
37	11	COMMA	COMMA	O	O	O
37	12	``	``	O	O	O
37	13	It	PRP	O	B-NP	O
37	14	is	VBZ	O	B-VP	O
37	15	time	NN	O	B-NP	O
37	16	for	IN	O	B-PP	O
37	17	the	DT	O	B-NP	O
37	18	scientific	JJ	O	I-NP	O
37	19	community	NN	O	I-NP	O
37	20	to	TO	O	B-VP	O
37	21	stop	VB	O	I-VP	O
37	22	giving	VBG	O	I-VP	O
37	23	alternative	NN	O	B-NP	B-Medical
37	24	medicine	NN	O	I-NP	B-Medical
37	25	a	DT	O	B-NP	O
37	26	free	JJ	O	I-NP	O
37	27	ride	NN	O	I-NP	O
37	28	.	.	O	O	O
37	29	''	''	O	O	O

38	0	&	CC	O	O	O
38	1	UR	NNP	O	B-NP	O
38	2	;	:	O	O	O
38	3	Dangerous	JJ	O	B-NP	O
38	4	Herbs	NNP	O	I-NP	O
38	5	&	CC	O	I-NP	O
38	6	LR	NNP	O	I-NP	O
38	7	;	:	O	O	O

39	0	The	DT	O	B-NP	O
39	1	September	NNP	O	I-NP	B-Date
39	2	issue	NN	O	I-NP	O
39	3	of	IN	O	B-PP	O
39	4	the	DT	O	B-NP	O
39	5	magazine	NN	O	I-NP	O
39	6	New	NNP	O	B-NP	O
39	7	Choices	NNS	O	I-NP	O
39	8	:	:	O	O	O
39	9	Living	VBG	O	B-VP	O
39	10	Even	RB	O	B-NP	O
39	11	Better	NNP	O	I-NP	O
39	12	After	IN	O	B-PP	O
39	13	50	CD	O	B-NP	B-Num
39	14	cautions	NNS	O	I-NP	O
39	15	against	IN	O	B-PP	O
39	16	taking	VBG	O	B-VP	O
39	17	five	CD	O	B-NP	B-Num
39	18	herbal	JJ	O	I-NP	O
39	19	remedies	NNS	O	I-NP	O
39	20	that	IN	O	O	O
39	21	the	DT	O	B-NP	O
39	22	editors	NNS	O	I-NP	B-ProfTitle
39	23	listed	VBN	O	B-VP	O
39	24	as	IN	O	B-PP	O
39	25	among	IN	O	B-PP	O
39	26	those	DT	O	B-NP	O
39	27	that	IN	O	O	O
39	28	``	``	O	O	O
39	29	can	MD	O	B-VP	O
39	30	trigger	VB	O	I-VP	O
39	31	serious	JJ	O	B-NP	O
39	32	side	NN	O	I-NP	O
39	33	effects	NNS	O	I-NP	O
39	34	or	CC	O	O	O
39	35	toxic	JJ	O	B-NP	B-Medical
39	36	reactions	NNS	O	I-NP	O
39	37	.	.	O	O	O
39	38	''	''	O	O	O

40	0	These	DT	O	B-NP	O
40	1	are	VBP	O	B-VP	O
40	2	the	DT	O	B-NP	O
40	3	herbs	NNS	O	I-NP	O
40	4	:	:	O	O	O

41	0	CHAPARRAL	NNP	O	B-NP	O
41	1	_	NN	O	I-NP	O
41	2	Also	RB	O	B-VP	O
41	3	called	VBN	O	I-VP	O
41	4	creosote	NN	O	B-NP	O
41	5	bush	NN	O	I-NP	O
41	6	COMMA	COMMA	O	O	O
41	7	it	PRP	O	B-NP	O
41	8	may	MD	O	B-VP	O
41	9	cause	VB	O	I-VP	O
41	10	acute	JJ	O	B-NP	B-Medical
41	11	nonviral	JJ	O	I-NP	O
41	12	hepatitis	NN	O	I-NP	B-Medical
41	13	-LBR-	-LBR-	O	I-NP	O
41	14	rapidly	RB	O	I-NP	O
41	15	developing	VBG	O	I-NP	O
41	16	liver	NN	O	I-NP	O
41	17	damage	NN	O	I-NP	O
41	18	-RBR-	-RBR-	O	I-NP	O
41	19	that	DT	O	I-NP	O
41	20	is	VBZ	O	B-VP	O
41	21	sometimes	RB	O	O	O
41	22	irreversible	JJ	O	O	O
41	23	.	.	O	O	O

42	0	COMFREY	NNP	O	B-NP	O
42	1	_	NN	O	I-NP	O
42	2	Has	VBZ	O	B-VP	O
42	3	been	VBN	O	I-VP	O
42	4	linked	VBN	O	I-VP	O
42	5	to	TO	O	B-PP	O
42	6	obstruction	NN	O	B-NP	O
42	7	of	IN	O	B-PP	O
42	8	blood	NN	O	B-NP	O
42	9	flow	NN	O	I-NP	O
42	10	from	IN	O	B-PP	O
42	11	the	DT	O	B-NP	O
42	12	liver	NN	O	I-NP	O
42	13	COMMA	COMMA	O	O	O
42	14	possibly	RB	O	O	O
42	15	causing	VBG	O	B-VP	O
42	16	irreversible	JJ	O	B-NP	O
42	17	scarring	NN	O	I-NP	B-Medical
42	18	of	IN	O	B-PP	O
42	19	the	DT	O	B-NP	O
42	20	liver	NN	O	I-NP	O
42	21	.	.	O	O	O

43	0	GERMANDER	NNP	O	B-NP	O
43	1	_	NN	O	I-NP	O
43	2	Is	VBZ	O	O	O
43	3	mixed	VBN	O	O	O
43	4	with	IN	O	B-PP	O
43	5	other	JJ	O	B-NP	O
43	6	herbs	NNS	O	I-NP	O
43	7	to	TO	O	B-VP	O
43	8	treat	VB	O	I-VP	O
43	9	obesity	NN	O	B-NP	B-Medical
43	10	.	.	O	O	O

44	0	In	IN	O	B-PP	O
44	1	France	NNP	O	B-NP	B-LocCoun
44	2	it	PRP	O	B-NP	O
44	3	has	VBZ	O	B-VP	O
44	4	been	VBN	O	I-VP	O
44	5	linked	VBN	O	I-VP	O
44	6	to	TO	O	B-PP	O
44	7	at	IN	O	B-NP	O
44	8	least	JJS	O	I-NP	O
44	9	27	CD	O	I-NP	B-Num
44	10	cases	NNS	O	I-NP	O
44	11	of	IN	O	B-PP	O
44	12	acute	JJ	O	B-NP	B-Medical
44	13	nonviral	JJ	O	I-NP	O
44	14	hepatitis	NN	O	I-NP	B-Medical
44	15	.	.	O	O	O

45	0	LOBELIA	NNP	O	O	O
45	1	_	NN	O	O	O
45	2	In	IN	O	B-PP	O
45	3	low	JJ	O	B-NP	O
45	4	doses	NNS	O	I-NP	O
45	5	COMMA	COMMA	O	O	O
45	6	can	MD	O	B-VP	O
45	7	result	VB	O	I-VP	O
45	8	in	IN	O	B-PP	O
45	9	respiratory	JJ	O	B-NP	B-Medical
45	10	depression	NN	O	I-NP	B-Medical
45	11	COMMA	COMMA	O	O	O
45	12	rapid	JJ	O	B-NP	O
45	13	heart	NN	O	I-NP	B-Medical
45	14	rate	NN	O	I-NP	I-Medical
45	15	and	CC	O	I-NP	O
45	16	coma	NN	O	I-NP	O
45	17	.	.	O	O	O

46	0	YOHIMBE	NNP	O	B-NP	O
46	1	_	NN	O	I-NP	O
46	2	Is	VBZ	O	B-VP	O
46	3	found	VBN	O	I-VP	O
46	4	in	IN	O	B-PP	O
46	5	body-building	JJ	O	B-NP	B-Medical
46	6	products	NNS	O	I-NP	O
46	7	COMMA	COMMA	O	O	O
46	8	which	WDT	O	B-NP	O
46	9	the	DT	O	B-NP	O
46	10	Food	NNP	O	I-NP	B-Loc
46	11	and	CC	O	I-NP	O
46	12	Drug	NNP	O	I-NP	B-Peop
46	13	Administration	NNP	O	I-NP	I-Peop
46	14	has	VBZ	O	B-VP	O
46	15	associated	VBN	O	I-VP	O
46	16	with	IN	O	B-PP	O
46	17	kidney	NN	O	B-NP	B-Medical
46	18	failure	NN	O	I-NP	I-Medical
46	19	COMMA	COMMA	O	O	O
46	20	seizures	NNS	O	B-NP	O
46	21	and	CC	O	I-NP	O
46	22	death	NN	O	I-NP	O
46	23	.	.	O	O	O
